Mayo Clinic aids discovery of first dystonia gene found in African-Americans

March 06, 2013

JACKSONVILLE, Fla. -- A pair of studies tells the tale of how a neuroscientist at Mayo Clinic in Florida helped to discover the first African-American family to have inherited the rare movement disorder dystonia, which causes repetitive muscle contractions and twisting, resulting in abnormal posture. The research may improve diagnosis of this neurological condition in a population not known to suffer from it.

In the first study, published in 2011 in the journal Parkinsonism and Related Disorders, Mayo Clinic's Zbigniew Wszolek, M.D., and a team of neuroscientists from other institutions in the U.S. described three generations of an African-American family in Georgia who had dystonia. The team excluded mutations in genes previously associated with dystonia. The study was the first description of an African-American family with late-onset primary dystonia.

In the second study, published online this week in Human Molecular Genetics, Dr. Wszolek was part of an international team of researchers led by Mark LeDoux, M.D., Ph.D., a neurologist and neurogeneticist from the University of Tennessee Health Science Center in Memphis. The investigators identified the specific genetic abnormality seen in the African-American family and in several other white families. In the African-American family, the mutation produced a protein in which one amino acid was substituted for another.

While this isn't the only gene anomaly linked to dystonia, it is the first found in an African-American family. All other genes found to be linked to this disorder were discovered in families of other ethnic origins.

The findings may improve diagnosis and treatment of dystonia in African-Americans, says Dr. Wszolek, who has been a driving force behind international research efforts to uncover genes that play a role in neurological disorders.

"This is a very hard disease to diagnose," Dr. Wszolek says. "The patient who came to see me had been to many other physicians who did not help him. His disorder, which resulted in contortions of his upper body, led to the loss of his job, and it meant that he couldn't drive because he was not able to keep his head straight to see in front of him," Dr. Wszolek says.

Through work with the patient, Dr. Wszolek came to know the rest of his family, which allowed him to do the genetic work that was critical to discovery of the mutated gene.

When dystonia was finally diagnosed in the patient, Dr. Wszolek and the Mayo Clinic health care team treated him with botulinum toxin (also known as Botox) to reduce muscle spasms and improve his head position.

"Our study now tells physicians that dystonia can occur in African-American patients, and that a blood sample that reveals a genetic abnormality can help diagnose the disease," Dr. Wszolek says. "There is no cure, but treatment can really help. Now the patient has less pain, he can drive and he works part time."
Both clinical and genetic studies were supported, in part, by the Dystonia Medical Research Foundation.

About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit and

Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.

Mayo Clinic

Related Dystonia Articles from Brightsurf:

Researchers find brain cell that triggers tremor and how to control it
Researchers have improved our understanding of how tremor -- the most common movement disorder -- happens, opening the possibility of novel therapies for this condition.

An oral splint that can reduce Tourette syndrome tics
Osaka University researchers developed a new device that ameliorates the characteristic vocal and motor tics of Tourette syndrome.

Mayo Clinic researchers uncover methods to quantify the yips and golfer's cramp
Almost every golfer knows the feeling. Minutes after a picture-perfect drive down the fairway, a cascade of inexplicable missed putts leads to a disappointing triple bogey.

Lightning carries potential danger to people with deep brain stimulators
Patients receiving deep brain stimulation are warned that their neurostimulators may dysfunction when confronted by electromagnetic fields generated by particular electrical devices found at work, home, and in the hospital.

Mass. General-led team identifies genetic defect that may cause rare movement disorder
A Massachusetts General Hospital-led research team has found that a defect in transcription of the TAF1 gene may be the cause of X-linked dystonia parkinsonism (XDP), a rare and severe neurodegenerative disease.

Deep brain stimulation: Improving outcomes in the treatment of movement disorders
For the first time, researchers from Charité have shown that, in patients with a type of movement disorder known as dystonia, a particular pattern of brain activity is linked to both the severity of symptoms and the clinical outcomes achieved through deep brain stimulation.

New botulinum neurotoxin discovered -- potential to treat a number of medical conditions
The first new botulinum neurotoxin in almost half a century has been discovered by researchers at Stockholm University and Harvard Medical School.

Review: Insomnia medication may wake up some patients from vegetative state
A systematic review of zolpidem for noninsomnia neurological disorders, including movement disorders and disorders of consciousness, finds reason for additional research.

Cause of an inherited neurological disorder discovered
Researchers at the University of Liverpool have identified the basis for how a single gene mutation can cause a rare neurological movement disorder known as dystonia.

Remarkable recovery in patients diagnosed with newly defined movement disorder
A team of researchers from UCL Great Ormond Street Institute of Child Health, University of Cambridge and the NIHR Rare Disease Bioresource have identified mutations in the KMT2B gene in 28 patients with dystonia.

Read More: Dystonia News and Dystonia Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to